Hi All,well bring it on, lets double the dividend and some.... Numbers are stacking up nicely, PE and payout ratios.. Hope they double up again @ the annual!!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%